Navigation Links
Glaucoma can Be Cured by Oven Cleaner!

Scientists have found a cure for one of the worlds leading causes of blindness in an oven cleaner.

Drops containing a substance commonly used to polish glass and remove grease could be used to treat glaucoma, claim researchers.

University of Central Florida scientists report in the latest issue of the Journal of Physical Chemistry B that cerium oxide nanoparticles (nanoceria), a common ingredient in oven cleaners, not only inhibits carbonic anhydrase II enzyme, but also tends to have pretty good absorption rates across the cornea.

Sudipta Seal, lead researcher at University of Central Florida, was testing cerium oxide nanoparticles, or nanoceria, for use as a catalyst to remove grime from oven walls, when he realised they might have medical applications.

"Before using any nanoparticles we have to check for toxicity," New Scientist quoted Seal, as saying.

Seal added that the substance did not irritate the eye when it was tested on both rats and rabbits and in some cases they helped protect cells from light damage.

"We realised that nanoceria might make a good vessel for delivering drugs directly into the eye," says Seal.

Glaucoma involves an irregular accumulation of fluid inside the eye. Existing eye-drop treatments contain chemicals that don't attach to transport proteins very successfully, so only a small amount gets through the cornea.

Now Seal and colleague Sanku Mallik have effectively combined nanoceria with a compound that blocks the hCAII enzyme, which is involved in producing fluid inside the eye.

At around 10 nanometres wide, the nanoceria are the right size and shape to make a way into the cornea.

"We hope to have a high concentration of the drug reaching inside the eye, also allowing us to cut down on the dosage needed," Mallik said.


'"/>




Page: 1

Related medicine news :

1. Glaucoma may be delayed by eye drops
2. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
3. Progression of Glaucoma could be controlled with early detection
4. Early Screening Required for Glaucoma
5. Adding An Additional Drug May Help Patients With Glaucoma
6. Heavy Computer Use May Result In Glaucoma
7. A Drop a day Can Keep Glaucoma At Bay
8. Millions Of Diabetic And Glaucoma Patients Risk Blindness
9. Glaucoma Could Cause Vision Loss In 60 Million People By 2010
10. Glaucoma Camp Held
11. Type 2 Diabetes Increases the Risk of Glaucoma in Women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... February 08, 2016 , ... ... Houma, LA, celebrates the beginning of a new charity campaign. As part of ... Appointed Special Advocates (CASA). In the belief that children deserve a voice, and ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... If you ... much to handle, you are not alone. According to the Center for Disease Control ... disease, stroke, type 2 diabetes and certain types of cancer, some of the leading ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... program serving the greater Venice, FL area, has initiated a fundraiser for a ... car accident just four days after Christmas. To support this beautiful child who ...
(Date:2/8/2016)... ... February 08, 2016 , ... Eating disorders and post-traumatic ... of women and men with eating disorders report a history of trauma, research ... development of an eating disorder. , At the 2016 iaedp Symposium, the ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Association of ... AHCC and the Home Health and Hospice ICD-10 Transition Workgroup are working closely ... coding guidance and clarifications, to address concerns over the use of 'A' as ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016  HemaFlo Therapeutics, Inc. announced today that ... US Patent Number 9,119,880 covering the use of NephroFlow to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ... --> Dale Peterson , PhD, HemaFlo,s ...
(Date:2/8/2016)... Feb. 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... editing, announced that the U.S. Food and Drug ... Drug (IND) application for SB-318, a single treatment ... Mucopolysaccharidosis Type I (MPS I). The SB-318 IND ... initiate a Phase 1/2 clinical study (SB-318-1502) designed ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology: